Products
Tetracaine is commercially available in the form of eye drops (Tetracaine). It has been approved in many countries since 1987.
Structure and properties
Tetracaine (C15H24N2O2, Mr = 264.4 g/mol) is present in drugs as tetracaine hydrochloride, a white, crystalline, and slightly hygroscopic powder that is readily soluble in water. It belongs to the ester-type local anesthetics and is also known as amethocaine.
Effects
Tetracaine (ATC S01HA03) has local anesthetic properties. Effects occur rapidly and last for at least 15 minutes. Effects disappear within 20 to 60 minutes.
Indications
For local anesthesia in ophthalmology.
Dosage
According to the professional information. Usually one drop is administered.
Contraindications
- Hypersensitivity
For complete precautions, see the drug label.
Interactions
Drug-drug interactions are possible with succinylcholine, sympathomimetics, sulfonamides, and beta-blockers.
Adverse effects
Possible adverse effects include local reactions such as irritation and burning. Systemic side effects cannot be ruled out. Corneal damage may occur with prolonged and improper use.
